Larimar Therapeutics, Inc. (LRMR) vs Avita Medical Inc. (RCEL)

A side-by-side comparison of Larimar Therapeutics, Inc. and Avita Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LRMR vs RCEL

growth of $100 · dividends reinvested · last 10y
LRMR -93.1% (-23.5%/yr)RCEL +79.1% (+6.0%/yr)RCEL compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$7$179
LRMR RCEL

LRMR vs RCEL: by the numbers

  • •RCEL is the larger company ($320M vs $291M market cap).
  • •Both run net losses; LRMR's is the smaller (0.00% vs -56.96% net margin).

Metrics side by side

Valuation

MetricLRMRRCEL
P/S ratioN/A4.23
P/B ratio2.29N/A

Profitability

MetricLRMRRCEL
Gross margin0.00%81.56%
Operating margin0.00%-59.40%
Net margin0.00%-56.96%
ROE-135.50%N/A
ROIC-136.49%-136.92%

Growth (annualized)

MetricLRMRRCEL
Revenue CAGR (5Y)N/A20.94%
Total return CAGR (5Y)-23.91%-5.28%

Frequently asked

How have LRMR and RCEL total returns compared?
Over the past 10 years, LRMR delivered -23.59% and RCEL delivered 4.36% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.